{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:liraglutide-injection",
  "slug": "liraglutide-injection",
  "title": "FDA shortage status: Liraglutide Injection",
  "ingredient": "Liraglutide Injection",
  "status": "current",
  "source_statuses": [
    "Current",
    "To Be Discontinued"
  ],
  "brand_names": [
    "LIRAGLUTIDE",
    "SAXENDA",
    "VICTOZA"
  ],
  "therapeutic_categories": [
    "Endocrinology/Metabolism"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "package_count": 10,
  "packages": [
    {
      "package_ndc": "0143-9144-02",
      "product_ndc": "0143-9144",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "SUBCUTANEOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "07/18/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0143-9144-03",
      "product_ndc": "0143-9144",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "SUBCUTANEOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "07/18/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-563-84",
      "product_ndc": "71288-563",
      "company_name": "Meitheal Pharmaceuticals, Inc.",
      "manufacturer_name": "Meitheal Pharmaceuticals Inc.",
      "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "SUBCUTANEOUS"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "07/18/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-563-85",
      "product_ndc": "71288-563",
      "company_name": "Meitheal Pharmaceuticals, Inc.",
      "manufacturer_name": "Meitheal Pharmaceuticals Inc.",
      "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "SUBCUTANEOUS"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "07/18/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0480-3667-20",
      "product_ndc": "0480-3667",
      "company_name": "Novo Nordisk, Inc.",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "SUBCUTANEOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/18/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0480-3667-22",
      "product_ndc": "0480-3667",
      "company_name": "Novo Nordisk, Inc.",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "SUBCUTANEOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/18/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0169-2800-15",
      "product_ndc": "0169-2800",
      "company_name": "Novo Nordisk, Inc.",
      "manufacturer_name": "Novo Nordisk Pharmaceutical Industries, LP",
      "presentation": "Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "SUBCUTANEOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/18/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0169-4060-12",
      "product_ndc": "0169-4060",
      "company_name": "Novo Nordisk, Inc.",
      "manufacturer_name": "Novo Nordisk",
      "presentation": "Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "SUBCUTANEOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/18/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0169-4060-13",
      "product_ndc": "0169-4060",
      "company_name": "Novo Nordisk, Inc.",
      "manufacturer_name": "Novo Nordisk",
      "presentation": "Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "SUBCUTANEOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/18/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0480-7250-46",
      "product_ndc": "0480-7250",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Teva Pharmaceuticals, Inc.",
      "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [
        "SUBCUTANEOUS"
      ],
      "update_date": "05/14/2026",
      "initial_posting_date": "05/14/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 6,
    "Limited Availability": 3
  },
  "initial_posting_date": "05/14/2026",
  "latest_source_update": "08/17/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}